Zdrowie i gospodarka · 16/10/2020

FDA Announces Final Guidance on Biotin Interference Testing for In Vitro Diagnostic Devices

The US Food and Drug Administration (FDA) has released a final guidance document outlining its recommendations for testing biotin interference in in vitro diagnostic devices, aiming to improve the accuracy and reliability of these devices in clinical settings.